Customers shopping at Wal-Mart in China. (Elizabeth Dalziel/AP Photo)
Customers shopping at Wal-Mart in China. (Elizabeth Dalziel/AP Photo)
Customers shopping at Wal-Mart in China. (Elizabeth Dalziel/AP Photo)

(Reuters) – China will allow online sales of prescription drugs as early as this month, a policy that will open up an over 1 trillion yuan ($161 billion) market to online pharmacy operators like Alibaba Group Holding Ltd and Wal-Mart Stores Inc.

The China Food and Drug Administration (CFDA) is finalising which prescription medicines to approve for sale, a senior healthcare policy adviser told Reuters.

The policy would help reform a fragmented and opaque market controlled by state-run distributors and hospitals, brought into the spotlight last year by a bribery case which saw drugmaker GlaxoSmithKline PLC fined nearly $500 million.

“The policy will be released in January or February and the CFDA is actively working on it,” said the adviser, who was not authorised to speak with media on the matter and so declined to be identified.

READ MORE

Leave a comment

Your email address will not be published.